SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

ZAULI, Giorgio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.939
AS - Asia 11.407
EU - Europa 7.839
SA - Sud America 2.129
AF - Africa 194
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 47.546
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.482
SG - Singapore 4.694
CN - Cina 3.300
IT - Italia 1.967
BR - Brasile 1.824
UA - Ucraina 1.263
DE - Germania 1.241
HK - Hong Kong 1.075
TR - Turchia 849
PL - Polonia 839
GB - Regno Unito 782
VN - Vietnam 661
FI - Finlandia 410
RU - Federazione Russa 366
SE - Svezia 320
CA - Canada 241
ID - Indonesia 189
MX - Messico 178
IN - India 145
FR - Francia 140
NL - Olanda 138
AR - Argentina 131
ZA - Sudafrica 102
BD - Bangladesh 84
ES - Italia 81
JP - Giappone 81
BE - Belgio 60
EC - Ecuador 54
IQ - Iraq 47
LT - Lituania 47
AT - Austria 41
CZ - Repubblica Ceca 37
PK - Pakistan 32
SA - Arabia Saudita 29
CO - Colombia 27
VE - Venezuela 27
AU - Australia 25
IR - Iran 25
UZ - Uzbekistan 22
JO - Giordania 20
EG - Egitto 19
PY - Paraguay 18
KR - Corea 17
AE - Emirati Arabi Uniti 16
CL - Cile 16
MA - Marocco 16
AZ - Azerbaigian 15
IL - Israele 15
TN - Tunisia 15
DZ - Algeria 14
EE - Estonia 14
UY - Uruguay 14
AL - Albania 13
LK - Sri Lanka 13
RO - Romania 13
CH - Svizzera 11
IE - Irlanda 11
NP - Nepal 11
PE - Perù 11
KE - Kenya 10
BG - Bulgaria 8
DO - Repubblica Dominicana 8
GE - Georgia 8
KG - Kirghizistan 8
KZ - Kazakistan 8
TW - Taiwan 8
JM - Giamaica 7
HN - Honduras 6
MY - Malesia 6
OM - Oman 6
CR - Costa Rica 5
NO - Norvegia 5
PT - Portogallo 5
EU - Europa 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BH - Bahrain 3
BO - Bolivia 3
CI - Costa d'Avorio 3
DK - Danimarca 3
KW - Kuwait 3
MD - Moldavia 3
PH - Filippine 3
SN - Senegal 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BS - Bahamas 2
BW - Botswana 2
ET - Etiopia 2
GR - Grecia 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SR - Suriname 2
TZ - Tanzania 2
Totale 47.518
Salva come PNG Salva come JPEG
Città #
Fairfield 3.039
Woodbridge 2.826
Ashburn 2.600
Singapore 2.536
Houston 1.757
Jacksonville 1.385
Ann Arbor 1.271
Chandler 1.231
Seattle 1.204
Beijing 1.095
Cambridge 1.071
Hong Kong 1.066
Santa Clara 1.066
Wilmington 1.062
Warsaw 817
Ferrara 526
Izmir 490
Dallas 443
Los Angeles 425
Nanjing 389
Princeton 311
New York 297
Munich 254
Boardman 253
San Diego 240
Ho Chi Minh City 234
Milan 212
São Paulo 171
Shanghai 163
Jakarta 151
Shenyang 128
Nanchang 124
Mexico City 115
Buffalo 112
Hanoi 111
Dearborn 110
Hefei 97
Tianjin 96
London 94
Turku 89
Bologna 86
Chicago 82
The Dalles 77
Changsha 76
Montreal 74
Denver 71
Hebei 70
Johannesburg 69
Moscow 66
Brooklyn 65
Tokyo 64
Jiaxing 63
Rome 63
Dong Ket 62
Columbus 61
Falls Church 61
Mountain View 60
Stockholm 59
Brussels 58
Toronto 56
Bremen 55
Jinan 54
Chennai 53
Poplar 53
Frankfurt am Main 52
San Francisco 51
Helsinki 50
San Mateo 50
Norwalk 48
Zhengzhou 48
Orem 47
Kunming 46
Boston 44
Atlanta 42
Auburn Hills 42
Falkenstein 42
Rio de Janeiro 42
Council Bluffs 40
Phoenix 39
Belo Horizonte 38
Redwood City 38
Curitiba 33
Tappahannock 33
Ankara 32
Manchester 32
Nuremberg 31
Orange 31
Porto Alegre 31
Guangzhou 29
Da Nang 27
Ottawa 26
Brasília 25
Mumbai 24
Philadelphia 24
Verona 24
Addison 23
Augusta 23
Washington 23
Brno 22
Campinas 20
Totale 32.491
Salva come PNG Salva come JPEG
Nome #
Trattato di Anatomia Umana 316
Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice—from a human poisoning case to the preclinical evidence 298
Trattato di Anatomia Umana 297
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 263
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 260
Targeting mTOR in Acute Lymphoblastic Leukemia 257
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines 252
Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in Cognitive Impairment Diseases 243
Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model 242
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 238
MDM2/X inhibitors under clinical evaluation: Perspectives for the management of hematological malignancies and pediatric cancer 236
Cardiovascular disease-related miRNAs expression: Potential role as biomarkers and effects of training exercise 234
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 233
Changes of nuclear protein kinase C activity and isotype composition in PC12 cell proliferation and differentiation 230
Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia 227
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells 224
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia 220
Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia 220
Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells 219
Targeting the phosphatidylinositol 3-kinase/Akt/mechanistic target of rapamycin signaling pathway in B-lineage acute lymphoblastic leukemia: An update 219
Antiangiogenic activity of the MDM2 antagonist nutlin-3 217
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 215
Cytokine levels in the serum of healthy subjects 214
Association of serum tumor necrosis factor-related apoptosis inducing ligand with body fat distribution as assessed by dual X-rays absorptiometry 213
An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently tat-transfected cells and required for optimal HIV-1 LTR transactivating activity 213
Impact of physical exercise in cancer survivors during and after antineoplastic treatments 211
Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells 209
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism 209
Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye 205
COVID-19 and individual genetic susceptibility/receptivity: Role of ACE1/ACE2 genes, immunity, inflammation and coagulation. might the double x-chromosome in females be protective against SARS-COV-2 compared to the single x-chromosome in males? 205
Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults 203
HelixComplex snail mucus exhibits pro-survival, proliferative and pro-migration effects on mammalian fibroblasts 201
Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments 200
All-trans retinoic acid shows multiple effects on the survival, proliferation and differentiation of human fetal CD34+ haemopoietic progenitor cells. 199
Association between thyroid hormones and TRAIL 199
Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging 197
GM-CSF Exhibits Anti-Inflammatory Activity on Endothelial Cells Derived from Chronic Venous Disease Patients 195
Multiple dye-doped NIR-emitting silica nanoparticles for both flow cytometry and in vivo imaging 195
The circulating levels of TRAIL are extremely low after delivery but rapidly recover in both mothers and newborns 195
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 195
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-hodgkin's lymphoma xenografts 193
Actively targeted nanocarriers for drug delivery to cancer cells 192
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53(wild-type) JVM-2 But Not Towards p53(mutated) BJAB Leukemic Cells 190
Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70 190
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 189
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes 188
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL) 187
A Brain Hidden in the Ferrara Cathedral: A Novel Interpretation of a Renaissance Masterpiece 187
The MDM-2 antagonist nutlin-3 promotes the maturation of acute myeloid leukemic blasts 186
TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications 186
Serum Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Levels in Older Subjects with Dementia and Mild Cognitive Impairment 186
Clinical perspectives of TRAIL: Insights into central nervous system disorders 186
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets 186
Stroma-derived factor 1α induces a selective inhibition of human erythroid development via the functional upregulation of Fas/CD95 ligand 185
HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells 183
Association of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) with Central Adiposity and Low-Density Lipoprotein Cholesterol 183
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells 183
TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release 182
Flow cytometric quantification of HIV-1 Tat protein in tat-transfected Jurkat T cell lines 182
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells 182
TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress 181
Extracellular HIV-1 tat protein activates phosphatidylinositol 3- and Akt/PKB kinases in CD4+ T lymphoblastoid jurkat cells 180
Lovastatin dose-dependently potentiates the pro-inflammatory activity of lipopolysaccharide both in vitro and in vivo 180
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy 180
Human Herpesvirus 7 infection induces profound cell cycle perturbations coupled to disregulation of cdc2 and cyclin B and polyploidization of CD4+ T Cells 178
HIV-1 Tat protein down-regulates CREB transcription factor expression in PC12 neuronal cells through a phosphatidylinositol 3-kinase/AKT/cyclic nucleoside phosphodiesterase pathway 178
In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody. 178
In vitro growth of human fetal CD34+ cells in the presence of various combinations of recombinant cytokines under serum-free culture conditions 178
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 177
Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity 176
MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway 175
Redox signaling and oxidative stress: Cross talk with TNF-related apoptosis inducing ligand activity 175
Proper design of silica nanoparticles combines high brightness, lack of cytotoxicity and efficient cell endocytosis 174
Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells 174
Circulating levels of frizzled-related protein (FRZB) are increased in patients with early rheumatoid arthritis and decrease in response to disease-modifying antirheumatic drugs. 172
Circulating TRAIL shows a significant post-partum decline associated to stressful conditions 171
Multimodal near-infrared-emitting PluS Silica nanoparticles with fluorescent, photoacoustic, and photothermal capabilities 171
Influence of physical exercise on microRNAs in skeletal muscle regeneration, aging and diseases 171
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 170
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 170
HIV-1 Tat induces tyrosine phosphorylation of p125(FAK) and its association with phosphoinositide 3-kinase in PC12 cells 169
Molecular targets for selective killing of TRAIL-resistant leukemic cells. 169
Extracellular HIV-1 Tat protein differentially activates the JNK and ERK/MAPK pathways in CD4 T cells 167
Exogenous human immunodeficiency virus type‐1 Tat protein selectively stimulates a phosphatidylinositol‐specific phospholipase C nuclear pathway in the Jurkat T cell line 167
Mesenchymal stem cells display hepato-protective activity in lymphoma bearing xenografts 167
Roles and clinical implications of microRNAs in acute lymphoblastic leukemia 166
HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: A potential molecular mechanism to escape TRAIL cytotoxicity 165
Involvement of TRAIL/TRAIL-receptors in human intestinal cell differentiation 165
Engagement of CD28 modulates CXC chemokine receptor 4 surface expression in both resting and CD3-stimulated CD4+ T cells 165
Applications of nanoparticles in cancer medicine and beyond: optical and multimodal in vivo imaging, tissue targeting and drug delivery 165
Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells 165
The CD4 receptor plays essential but distinct roles in HIV‐1 infection and induction of apoptosis in primary bone marrow GPIIb/IIIa+ megakaryocytes and the HEL cell line 164
State of art and recent developments of anti-cancer strategies based on TRAIL 162
Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells 160
Two-gene mutation in a single patient: Biochemical and functional analysis for a correct interpretation of exome results 159
Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication 158
The MDM2 inhibitor Nutlin-3 attenuates streptozotocin-induced diabetes mellitus and increases serum level of IL-12p40. 158
Cell-based therapies for diabetic complications. 158
Human Colostrum and Breast Milk Contain High Levels of TNF-Related Apoptosis-Inducing Ligand (TRAIL). 158
Nuclear translocation of protein kinase C-α and -ζ isoforms in HL-60 cells induced to differentiate along the granulocytic lineage by all-trans retinoic acid 157
Totale 19.517
Salva come PNG Salva come JPEG
Categoria #
all - tutte 219.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.760
Totale 221.927
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.140 0 0 0 0 0 546 262 595 177 718 526 316
2021/20223.048 109 312 243 136 158 180 158 177 119 257 363 836
2022/20233.019 334 136 119 357 462 472 103 271 387 52 186 140
2023/20241.541 179 207 73 42 106 195 61 147 42 41 64 384
2024/20257.965 257 192 604 332 995 610 356 485 1.372 775 1.125 862
2025/202611.517 2.133 961 1.984 2.733 3.033 673 0 0 0 0 0 0
Totale 48.212